The role of KLF2 in regulating hepatic lipogenesis and blood cholesterol homeostasis via the SCAP/SREBP pathway
Liver steatosis is a common metabolic disorder resulting from imbalanced lipid metabolism, which involves various processes such as de novo lipogenesis, fatty acid uptake, fatty acid oxidation, and VLDL secretion. In this study, we discovered that KLF2, a transcription factor, plays a crucial role i...
Main Authors: | Yuhong Huang, Yi Fan Wang, Xiong Zhong Ruan, Chi Wai Lau, Li Wang, Yu Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227523001451 |
Similar Items
-
RA-XII Suppresses the Development and Growth of Liver Cancer by Inhibition of Lipogenesis via SCAP-dependent SREBP Supression
by: Di Guo, et al.
Published: (2019-05-01) -
The Role of SCAP/SREBP as Central Regulators of Lipid Metabolism in Hepatic Steatosis
by: Preethi Chandrasekaran, et al.
Published: (2024-01-01) -
Cdk8 attenuates lipogenesis by inhibiting SREBP-dependent transcription in Drosophila
by: Xiao Li, et al.
Published: (2022-11-01) -
Targeting the SREBP-1/Hsa-Mir-497/SCAP/FASN Oncometabolic Axis Inhibits the Cancer Stem-like and Chemoresistant Phenotype of Non-Small Cell Lung Carcinoma Cells
by: Tung-Yu Tiong, et al.
Published: (2022-06-01) -
Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer
by: Qiushi Zhao, et al.
Published: (2022-07-01)